Treatment approaches and nursing considerations for non-Hodgkin's lymphoma

Semin Oncol Nurs. 2006 May;22(2):97-106. doi: 10.1016/j.soncn.2006.03.001.


Objective: To discuss some common non-Hodgkin's lymphoma subtypes, and current systemic approaches including chemotherapy, monoclonal antibodies, radioimmunotherapy, and vaccines.

Data sources: Research and review articles, textbooks, and guidelines

Conclusion: Non-Hodgkin's lymphoma is one of the most common types of malignancies for both men and women. It manifests itself in the lymph nodes, bone marrow, and extranodal sites, with or without B symptoms (fevers, sweats, weight loss) and it continues to be on the rise. Recent advances in treatment options have improved the potential for cure within its various subtypes, although much more work remains to be done.

Implications for nursing practice: Management of side effects remains a major challenge to nurses when caring for patients undergoing treatment.

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Cancer Vaccines / adverse effects
  • Cancer Vaccines / therapeutic use
  • Humans
  • Lymphoma, Non-Hodgkin / complications
  • Lymphoma, Non-Hodgkin / nursing*
  • Lymphoma, Non-Hodgkin / therapy*
  • Radioimmunotherapy / adverse effects


  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Cancer Vaccines